Tirzepatide is a medication that works by activating two hormone pathways (GLP-1 and GIP) to help regulate blood sugar and support weight loss
Ji X, Johnson WW, Sesay MA, Dickert L, Prasad SM, Ammon HL, et al
For the glucose-lowering indication, these are categorised as: Very common (affecting one in every 10 people): Nausea, diarrhoea, hypoglycaemia when used with a sulfonylurea or insulin
This protocol maintains copper supplementation supporting collagen synthesis without full daily intensity, potentially sustaining 60-80% of peak benefits at 50-70% of continuous use cost while avoiding complete benefit decline from full discontinuation
Ock KS, Ganbold EO, Park J, Cho K, Joo SW, Lee SY